Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases
- 25 June 2024
- journal article
- review article
- Published by Springer Nature in Pharmacological Reports
- Vol. 76 (4) , 679-692
Abstract
Neurodegenerative diseases (NDDs) pose a significant issue in healthcare, needing a thorough knowledge of their complex molecular mechanisms. A diverse set of cell signaling mediators and their interactions play critical roles in neuroinflammation. The release of pro-inflammatory mediators in response to neural dysfunction is detrimental to normal cell survival. Moreover, the important role of nuclear factor-κB (NF-κB) in the central nervous system through Toll-like receptor (TLR) activation has been well established. Therefore, through a comprehensive review of current research and experimentation, this investigation elucidates the interactions between novel pharmacological agents (TLR-4/NF-κB inhibitors) and neurodegeneration encompassing Alzheimer’s, Parkinson’s, Huntington’s disease, amyotrophic lateral sclerosis and stroke. Insights garnered from this exploration underscore the potential of TLR-4 as a therapeutic target. Through the revelation of these insights, our aim is to establish a foundation for the development of enhanced and focused therapeutic approaches in the continuous endeavor to combat neurodegeneration. This review thus serves as a roadmap, guiding future research endeavors toward innovative strategies for combatting the complex interplay between TLR-4 signaling and NDDs. Graphical abstractKeywords
This publication has 87 references indexed in Scilit:
- Wnt signalling pathways as mediators of neuroprotective mechanisms: therapeutic implications in strokeMolecular Biology Reports, 2024
- Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathiesBrain, Behavior, and Immunity, 2019
- Hesperetin Confers Neuroprotection by Regulating Nrf2/TLR4/NF-κB Signaling in an Aβ Mouse ModelMolecular Neurobiology, 2019
- Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer’s diseaseBrain, Behavior, and Immunity, 2017
- Gx‐50 reduces β‐amyloid‐induced TNF‐α, IL‐1β, NO, and PGE2 expression and inhibits NF‐κB signaling in a mouse model of Alzheimer's diseaseEuropean Journal of Immunology, 2015
- Protective Effect of Shikonin in Experimental Ischemic Stroke: Attenuated TLR4, p-p38MAPK, NF-κB, TNF-α and MMP-9 Expression, Up-Regulated Claudin-5 Expression, Ameliorated BBB PermeabilityNeurochemical Research, 2013
- The Role of Glia in Alpha-SynucleinopathiesMolecular Neurobiology, 2012
- Neuroinflammation modulates distinct regional and temporal clinical responses in ALS miceBrain, Behavior, and Immunity, 2011
- Deciphering the complexity of Toll-like receptor signalingCellular and Molecular Life Sciences, 2010
- Up-regulation of Toll-like receptor 4 was suppressed by emodin and baicalin in the setting of acute pancreatitisBiomedicine & Pharmacotherapy, 2009